Theresa Patton Email

VP Market Access . CymaBay Therapeutics

Current Roles

Employees:
122
Revenue:
$6.8M
About
CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPAR agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with non-alcoholic steatohepatitis (NASH). For additional information about CymaBay visit www.cymabay.com.
CymaBay Therapeutics Address
7575 Gateway Blvd
Newark, CA
United States
CymaBay Therapeutics Email

Past Companies

CymaBay Therapeutics
-
-

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.